Skip to main content
Clinical Trials/NCT02401841
NCT02401841UnknownNot Applicable

Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex

Policlinico Hospital1 site in 1 country40 target enrollmentStarted: January 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
Differences in neuro-muscular block resolution time between two groups

Study Overview

Brief Summary

It is a observational prospective study. The aim of this study is to compare neostigmine vs sugammadex in the resolution of neuro-muscular blockade in great obese patients.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Great obese
  • Videolaparoscopic surgery

Exclusion Criteria

  • Age under 18
  • No acceptation of informed consent
  • New York Heart Association > 2

Arms & Interventions

Sugammadex

Patients treated with Sugammadex

Intervention: Two different types of drug for resolution of neuro-muscular blockade (Drug)

Neostigmine

Patients treated with Neostigmine

Intervention: Two different types of drug for resolution of neuro-muscular blockade (Drug)

Outcomes

Primary Outcomes

Differences in neuro-muscular block resolution time between two groups

Time Frame: up to 36 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Policlinico Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Davide Chiumello

MD

Policlinico Hospital

Study Sites (1)

Loading locations...

Similar Trials

Resolution of Neuro-muscular Block in... | Clinical Trial